drugset / Trial / NCT00101335

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

NCT00101335 ↗

RandomizedDouble-blindPrevention

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of celecoxib may prevent or treat head and neck cancer. PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works compared to placebo in preventing head and neck cancer in patients with oral leukoplakia.

Timeline

Start
2003-11
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral